W. Shipley

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

ESUR prostate MR guidelines 2012

Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer

The rising prevalence of androgen deprivation among older American men since the advent of prostate‐specific antigen testing: a population‐based cohort study

The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study

Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate

Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology

Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer

EAU Guidelines on Prostate Cancer

Bladder cancer

Perineural Invasion is a Marker for Pathologically Advanced Disease in Localized Prostate Cancer

Urothelial carcinoma management in elderly or unfit patients

Cancer and Radiation Therapy: Current Advances and Future Directions

Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer

Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 patterns of care survey for prostate cancer

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Identification of a new human coronavirus

Radiotherapy: what can be achieved by technical improvements in dose delivery?

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

Therapeutic Opportunities in the Intrinsic Subtypes of Muscle-Invasive Bladder Cancer

Perineural invasion in cancer

Phylogenetic diversity of the Rickettsiae

How To Build and Interpret a Nomogram for Cancer Prognosis

Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila.

Androgen Suppression Plus Radiation Versus Radiation Alone for Patients With Stage D₁/Pathologic Node-Positive Adenocarcinoma of the Prostate: Updated Results Based on National Prospective Randomized Trial Radiation Therapy Oncology Group 85-31

Penile Length Changes in Men Treated With Androgen Suppression Plus Radiation Therapy for Local or Locally Advanced Prostate Cancer

Identification of an enzootic diarrhea (“Shasta river crud”) in Northern California as potomac horse fever

Characterization of a Coronavirus Isolated from a Diarrheic Foal

Reactive Oxygen Species (ROS)-Based Nanomedicine

Defining High Risk Prostate Cancer With Risk Groups and Nomograms: Implications for Designing Clinical Trials

Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology

Ehrlichia risticii sp. nov.: Etiological Agent of Equine Monocytic Ehrlichiosis (Synonym, Potomac Horse Fever)

Cancer de la prostate

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Preliminary Results of GETUG-01

Freedom from castration: an alternative end point for men with localized prostate cancer treated by external beam radiation therapy

Novel neoadjuvant therapy paradigms for bladder cancer: Results from the National Cancer Center Institute Forum

Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study

Progression free survival (PFS) after whole-pelvic (WP) vs. mini-pelvic (MP) or prostate only (PO) radiotherapy (RT): A subset analysis of RTOG 9413, a Phase III prospective randomized trial using neoadjuvant and concurrent (N&CHT)

A phase III trial comparing whole-pelvic (WP) to prostate only (PO) radiotherapy and neoadjuvant to adjuvant total androgen suppression (TAS): preliminary analysis of RTOG 9413

Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995

Isolation of coronavirus-like agent from horses suffering from acute equine diarrhoea syndrome

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413